Supernus Pharmaceuticals (SUPN) Q2 2021 Earnings

5MayConfirmed
Aug 20
Q4 2020
Q1 2021
Q2 2021
0.11
0.32
0.53
0.74

Details

Expected EPS
0.24
Actual EPS
0.11
Surprise EPS
-0.13
Surprise Percent
+54.17%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.11 per share for Q2 2021.

0 Comments

Share your thoughts